The expression and significance of TLR4-mediated immune escape signal transduction system in bladder urothelial carcinoma
-
摘要: 目的:探讨TLR-4介导的免疫逃逸信号转导系统在膀胱尿路上皮癌免疫逃逸机制中的作用及其与膀胱癌生物学行为的关系。方法:采用免疫组化染色法检测60例膀胱尿路上皮癌和10例正常膀胱组织中TLR-4、B7-H1、PD-1、Fas及FasL的表达。结果:TLR-4在正常膀胱组织中均有表达,而在膀胱尿路上皮癌中表达有所降低;B7-H1、PD-1、Fas、FasL在正常膀胱组织中无表达或表达极低,而在膀胱尿路上皮癌中的表达均明显增高,并且其表达与肿瘤的病理分级和临床分期密切相关,同时B7-H1表达与复发亦密切相关。结论:TLR-4介导的免疫逃逸信号转导系统可能与膀胱尿路上皮癌的免疫逃逸密切相关,在膀胱尿路上皮癌的发生发展中可能存在着TLR-4介导的免疫逃逸信号转导系统的活化和相关免疫抑制分子表达的上调。Abstract: Objective: To investigate the mechanism of the TLR-4-mediated immune escape signal transduction system in bladder urothelial carcinoma and their relationship with the biological behavior of bladder cancer. Method: Sampales from 60 patients with bladder urothelial carcinoma and 10 cases with normal bladder tissue were examined for TLR-4, B7-H1, PD-1, Fas and FasL expression by immunohistochemical staining Result: TLR-4 positivity was observed in all normal bladder tissue, while decreased expression in bladder urothelial carcinoma; There were no expression or very low expression of B7-H1, PD-1, Fas and FasL in normal bladder tissue, but in bladder urothelial carcinoma the positive expression of those proteins were significantly higher, and those proteins expression were closely correlated with tumor pothological grade and clinical stage, at the same time the B7-H1 expression was also correlated with recurrence.Conclusion: TLR-4-mediated signal transduction system may be associated with bladder urothelial carcinoma immune escape, and activation of TLR-4-mediated immune escape signal transduction system may exist in the development of bladder urothelial carcinoma and along with TLR-4-mediated signal transduction system related immunosuppressive molecule upregulation.
-
Key words:
- bladder urothelial carcinoma /
- immune escape
-
-
[1] 王永华, 庄乾元, 周四维, 等. 阻断B7-H1通路增强淋巴细胞抗膀胱肿瘤免疫效应的研究[J]. 中华实验外科杂志, 2009, 26(9):1226-1226.
[2] Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance[J]. Cancer Res, 2005, 65:5009-5014.
[3] Takeda K, Kaisho T, Akira S. Toll-like receptors[J]. Annu Rev Immunol, 2003, 21:335-376.
[4] Dong H, Chen L. B7-H1 pathway and its role in the evasion of tumor immunity[J]. J Mol Med, 2003, 81:281-287.
[5] Hahne M, Rimold D, Schroter M, et al. Melanoma cells expression of Fas (AP0-1/CD95) ligand:implications for tumor immune escape[J]. Science, 1996, 274:1363-1366.
[6] Cui H, Sherr D H, el-Khatib M, et al. Regulation of T-cell death genes:selective inhibition of FasL-but not Fas-mediated function[J]. Cell Immunol, 1996, 167:276-284.
[7] Ayari C, Bergeron A, LaRue H, et al. Toll-like receptors in normal and malignant human bladders[J]. J Urol, 2011, 185:1915-1921.
[8] 李杜渐, 杨宇如, 李响, 等. 单核细胞趋化因子及钟声蛋白样受体在卡介苗灌注膀胱局部抗肿瘤免疫反应中的表达[J]. 临床泌尿外科杂志, 2006, 21(11):859-862.
[9] Inman B A, Sebo T J, Frigola X, et al. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata:associations with localized stage progression[J]. Cancer, 2007, 109:1499-1505.
-
计量
- 文章访问数: 64
- PDF下载数: 87
- 施引文献: 0